|Name||Period of Training||Institution||Awards/Programs|
|Julie Eisengart, PhD||2009-2010||University of Minnesota||LDN Fellow; 9/2009 LDN Fellowship in Pediatric Neuropsychology; 12/2009 National Institutes of Health, Office of Rare Diseases, Conference Travel Award; 9/2010 Rare Diseases Clinical Research Network, Conference Travel Award; 2010 CCRRD LDN Trainee Participation|
|Jeanine Utz, PharmD||2009-2011||University of Minnesota||LDN Fellow; 2010 and 2012 CCRRD LDN Trainee Participation|
|Moin Vera, MD, PhD||2010||Harbor-UCLA Medical Center||LDN Fellow; Ruth L. Kirschstein NRSA Award; 2010 CCRRD LDN Trainee Participation|
|Jonica Hazaert, PharmD||2010-2012||University of Minnesota||LDN Fellow; Co-sponsored by Sanofi Genzyme|
|Sarah Lo, MD||2011-2012||Yale University||LDN Fellow|
|Wenyong Tong, PhD||2012||University of California San Diego||LDN Fellow; 2012 CCRRD LDN Trainee Participation|
|Alia Ahmed, MD||2012-2013||University of Minnesota||LDN Fellow; National MPS Society grant; 10/2012 Rare Diseases Clinical Research Network, Conference Travel Award; 2012 CCRRD LDN Trainee Participation|
|Patrick Sorgen, PharmD||2013-2014||University of Minnesota||LDN Fellow; Co-sponsored by Sanofi Genzyme|
|Kelly King, PhD||2013-2014||University of Minnesota||LDN Fellow|
|Lisa Coles, MS, PhD||2013-2014||University of Minnesota||LDN Fellow|
|Zoheb Kazi, MBBS||2013-2014||Duke University||LDN Fellow; 2016 CCRRD LDN Trainee Participation|
|Joseph Schneider, PharmD||2014-2015||University of Minnesota||LDN Fellow; Co-sponsored by Sanofi Genzyme; 2016 CCRRD LDN Trainee Participation|
|Mari Mori, MD||2014-2015||Duke University||LDN Fellow; 2016 CCRRD LDN Trainee Participation|
|Melani Solomon, PhD||2015-2016||University of Maryland||LDN Fellow; 2016 CCRRD LDN Trainee Participation|
|Zahra Karimian, PharmD||2015-2016||University of Minnesota||LDN Fellow; Co-sponsored by Sanofi Genzyme|
|Li Ou, PhD||2016-2017||University of Minnesota||LDN Fellow; 2016 CCRRD LDN Trainee Participation|
|Kwangchae Yoon, PharmD||2016-2018||University of Minnesota||LDN Fellow; Co-sponsored by Sanofi Genzyme; 2016 CCRRD LDN Trainee Participation|
|Michael Flanagan, PhD||2016-2017||St. Louis University||LDN Fellow; RDCRN Scholar Program; 2016 CCRRD LDN Trainee Participation|
|Reena Kartha, PhD||2016-2017||University of Minnesota||LDN Fellow; RDCRN Scholar Program; 2012 and 2016 CCRRD LDN Trainee Participation; University of Minnesota CTSI 2017 Junior Mentor of the Year|
|Laura Adang, MD, PhD||2017-2018||Children’s Hospital of Philadelphia||LDN Fellow; RDCRN Scholar Program; 2018 CCRRD LDN Trainee Participation|
|Ankit Desai, MBBS||2018-2019||Duke University||LDN Fellow|
|Reena Kartha, PhD||2018-2019||University of Minnesota||LDN Fellow; 2018 CCRRD LDN Trainee Participation|
|Todd Vanyo, PharmD||2018-2019||University of Minnesota||LDN Fellow|
|Michael Przybilla, PhD||2019-||University of Minnesota||LDN Fellow|
Utilizing NIH funding, the Lysosomal Disease Network Fellowship provides $50,000 total costs (direct and indirect costs) for an annual period beginning August 1 of any given year to July 31 of the following year. The LDN Fellowship can support currently-ongoing research projects, as well as new research projects. The projects are required to be of a clinical nature, working with people or human tissues; they cannot be non-human medical research.
SUBMISSION DEADLINE: In any given year, the usual application deadline is May 1st, although this could possibly vary. Incomplete or late applications are not accepted for review.
Completion of Forms:
Although the current NIH PHS 398 forms must be used (including Face Page, Budget and Budget Justification pages, etc.), the grant will be issued by the University of Minnesota to the applicant’s institution.
The fellowship application does not need to be vetted by the applicant’s institutional administration prior to submission.
The application should cite additional funds, if any, that will be used to support the applicant and the research project prior to, during, and after the Fellowship, in the “Other Support” section of the application (in the Biographical Sketch).
The current PHS 398 forms are available at this website: NIH PHS 398 forms
Application Review Criteria:
Be aware that it is especially important to abide by this applicant criteria: Applicants should be a recent post-doctoral professional who will develop an interest in clinical research of lysosomal diseases. Applications will be reviewed for focus on “clinical research” (using human subjects and/or human tissues) of “lysosomal diseases” with priority given to those applicants who are likely to be mentored into a career with a focus on clinical research of lysosomal diseases. The application will also be evaluated with respect to the applicant’s potential to submit a manuscript based on the research proposal to a peer-reviewed journal for publication.
Applications are required to be submitted by e-mail only (please do not send paper copies) by the specified deadline to this e-mail address: email@example.com. Questions can also be sent to that e-mail address. Thank you for your interest in this Fellowship.
The Rare Diseases Clinical Research Network (RDCRN) annually offers early-career rare disease researchers an excellent funded training and networking opportunity. This academic-year-long course consists of both in-person and remote sessions providing the tools and mentoring needed for a successful career in rare diseases clinical research. This competitive opportunity is available to researchers associated with one of the RDCRN’s research consortia. The Lysosomal Disease Network is one such RDCRN consortium.